Pharmaco(Epi)Genetic, Proteomic, and Microbiomic Study of Obsessive-Compulsive Disorder
NCT02431845
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
200
Enrollment
OTHER
Sponsor class
Conditions
Obsessive-Compulsive Disorder
Interventions
DRUG:
SSRIs
Sponsor
Severance Hospital